Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Safety and Efficacy

Principal Investigator

David M Kushner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wisconsin, Madison

Authority:

United States: Food and Drug Administration

Study ID:

CO 02701

NCT ID:

NCT00214058

Start Date:

August 2002

Completion Date:

February 2006

Related Keywords:

• Ovarian Carcinoma
• Primary Peritoneal Carcinoma
• Carcinoma
• Ovarian Neoplasms
• Neoplasms, Glandular and Epithelial

Name	Location
University of Wisconsin Hospital and Clinics	Madison, Wisconsin  53792-0001